Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
about
Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based studyConcurrent chemoradiotherapy with a novel fluoropyrimidine, S-1, and cisplatin for locally advanced esophageal cancer: long-term results of a phase II trial.GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcomePrognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapyRelative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer.Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy.Treatment of thoracic esophageal carcinoma invading adjacent structures.Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinomaImpact of endoscopic ultrasonography and physician specialty on the management of patients with esophagus cancer.Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan.Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapy.Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma.Multimodal treatment strategy for clinical T3 thoracic esophageal cancer.Chemoradiotherapy and surgery for T4 esophageal cancer in Japan.Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.Cetuximab in patients with esophageal cancer: a systematic review and meta-analysis of randomized controlled trials.High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis.The SCOPE of definitive chemoradiotherapy in locally advanced esophageal cancer: what direction for the future?Stage-directed individualized therapy in esophageal cancer.Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas.Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancerRole of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study.Shifting practice in definitive chemoradiation for localized esophageal cancer.Surveillance or resection after chemoradiation in esophageal cancer.Propensity score analysis of oesophageal cancer treatment with surgery or definitive chemoradiotherapy.Prognostic significance of total disease length in esophageal cancer.Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study.Changes in cardiac volume determined with repeated enhanced 4DCT during chemoradiotherapy for esophageal cancer
P2860
Q24648727-C8AFEC57-3528-4B5D-B968-32B354654799Q33407844-76C9B97A-F6FD-4A6E-81CF-ED27C53BFD80Q33710048-D8FEEA03-74D1-40EE-8662-344553E50184Q34980099-80D95B9F-E532-4C1D-BC90-D1CBD801B519Q35835137-E00D3F1B-BAF8-4A8F-AD9E-114EA42ECA65Q36140927-7D196C3D-B230-4B6F-BFE1-2722871B8FB5Q36699232-BC936C54-81B7-4D3A-8811-27B1B39BC77BQ36794837-EA643935-108A-4CE3-ADD6-BAE987B03AB5Q36940910-A77D20B9-0462-4111-A0D8-0B63264E4B84Q36959768-743C2505-6838-4A8F-911B-4FE9B2DA9308Q37207101-14BFF2A0-3298-47CA-BC37-2CB013DF7E9BQ37484572-D70B7FF0-CD83-4BEB-AB9F-79F585DC044BQ37580707-697257E4-511F-4D07-8482-DDCA13DA3D91Q38128743-DF67CAD9-1C2D-45DB-A050-7D3DD5A1E5FEQ38316252-B3B67904-DE31-44BA-894B-36A1FC1AE9D0Q38367708-CC0B32D7-B110-405B-B609-6C78809452B3Q38385570-3AF1499B-CC50-4D29-8AA2-452CEEC04568Q38559388-C8B77E2F-1DB2-4626-9791-DE66F4C46106Q38854234-70BE15E8-8EDD-4A5E-825C-ECFB7AC5B4C0Q38888100-030C0C79-1A67-42E8-9BD5-0D939322DCAEQ39157407-F484C76C-98FC-4BA9-8C0D-2E117E918E00Q39694301-FC12F5F3-9848-4566-8528-0C69C3CCABEDQ41212632-C52C10D4-6999-4E52-B996-E5B7B1CB3F64Q47168592-94E8FFCF-AB9F-4563-8E69-32D41BD8EA64Q53073167-42628962-C889-4B49-A8A0-278270BB6A6CQ53138654-B5527F16-B883-4059-AF79-C82896A031AEQ53379084-D3E4180D-33CF-4BAC-BA06-D091DAE4B1C0Q54169017-941D5915-A5A4-4516-87C0-D28966293861Q58725435-474DF155-02AE-4566-8879-408598D5D3B7
P2860
Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
@ast
Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
@en
type
label
Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
@ast
Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
@en
prefLabel
Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
@ast
Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
@en
P2093
P2860
P356
P1476
Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
@en
P2093
A E Brewster
L Perschky
P Kehagioglou
T D L Crosby
T S Maughan
P2860
P2888
P356
10.1038/SJ.BJC.6601461
P407
P577
2004-01-01T00:00:00Z